Stock Analysis
Retail investors in TECON BIOLOGY Co.LTD (SZSE:002100) are its biggest bettors, and their bets paid off as stock gained 6.0% last week
Key Insights
- The considerable ownership by retail investors in TECON BIOLOGYLTD indicates that they collectively have a greater say in management and business strategy
- The top 17 shareholders own 50% of the company
- 25% of TECON BIOLOGYLTD is held by Institutions
A look at the shareholders of TECON BIOLOGY Co.LTD (SZSE:002100) can tell us which group is most powerful. With 40% stake, retail investors possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
Clearly, retail investors benefitted the most after the company's market cap rose by CN¥546m last week.
Let's delve deeper into each type of owner of TECON BIOLOGYLTD, beginning with the chart below.
View our latest analysis for TECON BIOLOGYLTD
What Does The Institutional Ownership Tell Us About TECON BIOLOGYLTD?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
TECON BIOLOGYLTD already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see TECON BIOLOGYLTD's historic earnings and revenue below, but keep in mind there's always more to the story.
TECON BIOLOGYLTD is not owned by hedge funds. Xinjiang Production and Construction Corps Investment Co.,Ltd. is currently the largest shareholder, with 22% of shares outstanding. With 5.0% and 4.6% of the shares outstanding respectively, Beijing Rongyuan Baotong Asset Management Partnership Enterprise (LP) and Hainan Tianbang Hongkang Venture Capital Co., Ltd. are the second and third largest shareholders.
After doing some more digging, we found that the top 17 have the combined ownership of 50% in the company, suggesting that no single shareholder has significant control over the company.
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
Insider Ownership Of TECON BIOLOGYLTD
The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
We note our data does not show any board members holding shares, personally. It is unusual not to have at least some personal holdings by board members, so our data might be flawed. A good next step would be to check how much the CEO is paid.
General Public Ownership
The general public-- including retail investors -- own 40% stake in the company, and hence can't easily be ignored. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
Private Company Ownership
Our data indicates that Private Companies hold 35%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.
Next Steps:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too.
I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow, for free.
If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Valuation is complex, but we're here to simplify it.
Discover if TECON BIOLOGYLTD might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:002100
TECON BIOLOGYLTD
Engages in the provision of animal health care, feed, pig breeding, agricultural product processing and trade, and financial services in China and internationally.